KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Debt to Equity (2016 - 2020)

Neogenomics (NEO) has disclosed Debt to Equity for 11 consecutive years, with $0.19 as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Debt to Equity rose 376.23% year-over-year to $0.19, compared with a TTM value of $0.19 through Mar 2020, up 376.23%, and an annual FY2019 reading of $0.19, up 375.03% over the prior year.
  • Debt to Equity was $0.19 for Q1 2020 at Neogenomics, down from $0.19 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.6 in Q2 2018 and bottomed at $0.04 in Q1 2019.
  • Average Debt to Equity over 5 years is $0.27, with a median of $0.26 recorded in 2016.
  • The sharpest move saw Debt to Equity plummeted 90.15% in 2019, then skyrocketed 376.23% in 2020.
  • Year by year, Debt to Equity stood at $0.16 in 2016, then grew by 4.43% to $0.16 in 2017, then plummeted by 75.56% to $0.04 in 2018, then soared by 375.03% to $0.19 in 2019, then decreased by 0.8% to $0.19 in 2020.
  • Business Quant data shows Debt to Equity for NEO at $0.19 in Q1 2020, $0.19 in Q4 2019, and $0.2 in Q3 2019.